Literature DB >> 8655504

The Streptomyces peucetius drrC gene encodes a UvrA-like protein involved in daunorubicin resistance and production.

N Lomovskaya1, S K Hong, S U Kim, L Fonstein, K Furuya, R C Hutchinson.   

Abstract

The drrC gene, cloned from the daunorubicin (DNR)- and doxorubicin-producing strain of Streptomyces peucetius ATCC 29050, encodes a 764-amino-acid protein with a strong sequence similarity to the Escherichia coli and Micrococcus luteus UvrA proteins involved in excision repair of DNA. Expression of drrC was correlated with the timing of DNR production in the growth medium tested and was not dependent on the presence of DNR. Since introduction of drrC into Streptomyces lividans imparted a DNR resistance phenotype, this gene is believed to be a DNR resistance gene. The drrC gene could be disrupted in the non-DNR-producing S. peucetius dnrJ mutant but not in the wild-type strain, and the resulting dnrJ drrC double mutant was significantly more sensitive to DNR in efficiency-of-plating experiments. Expression of drrC in an E. coli uvrA strain conferred significant DNR resistance to this highly DNR-sensitive mutant. However, the DrrC protein did not complement the uvrA mutation to protect the mutant from the lethal effects of UV or mitomycin even though it enhanced the UV resistance of a uvrA+ strain. We speculate that the DrrC protein mediates a novel type of DNR resistance, possibly different from the mechanism of DNR resistance governed by the S. peucetius drrAB genes, which are believed to encode a DNR antiporter.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8655504      PMCID: PMC178076          DOI: 10.1128/jb.178.11.3238-3245.1996

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  38 in total

1.  [A NEW ANTIBIOTIC WITH CYTOSTATIC PROPERTIES: RUBIDOMYCIN].

Authors:  M DUBOST; P GANTER; R MARAL; L NINET; S PINNERT; J PREUDHOMME; G H WERNER
Journal:  C R Hebd Seances Acad Sci       Date:  1963-09-09

2.  Sequences of Escherichia coli uvrA gene and protein reveal two potential ATP binding sites.

Authors:  I Husain; B Van Houten; D C Thomas; A Sancar
Journal:  J Biol Chem       Date:  1986-04-15       Impact factor: 5.157

3.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

4.  Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.

Authors:  C Yanisch-Perron; J Vieira; J Messing
Journal:  Gene       Date:  1985       Impact factor: 3.688

5.  Interactions of the UVRABC endonuclease in vivo and in vitro with DNA damage produced by antineoplastic anthracyclines.

Authors:  B M Kacinski; W D Rupp
Journal:  Cancer Res       Date:  1984-08       Impact factor: 12.701

6.  Mutational cloning in Streptomyces and the isolation of antibiotic production genes.

Authors:  K F Chater; C J Bruton
Journal:  Gene       Date:  1983-12       Impact factor: 3.688

7.  Plasmids, recombination and chromosome mapping in Streptomyces lividans 66.

Authors:  D A Hopwood; T Kieser; H M Wright; M J Bibb
Journal:  J Gen Microbiol       Date:  1983-07

8.  Nutrient effects on anthracycline production by Streptomyces peucetius in a defined medium.

Authors:  M L Dekleva; J A Titus; W R Strohl
Journal:  Can J Microbiol       Date:  1985-03       Impact factor: 2.419

9.  Characterization of temperate actinophage phi C31 isolated from Streptomyces coelicolor A3(2).

Authors:  N D Lomovskaya; N M Mkrtumian; N L Gostimskaya; V N Danilenko
Journal:  J Virol       Date:  1972-02       Impact factor: 5.103

10.  Transformation and transfection of anthracycline-producing streptomycetes.

Authors:  J S Lampel; W R Strohl
Journal:  Appl Environ Microbiol       Date:  1986-01       Impact factor: 4.792

View more
  22 in total

1.  A phylogenomic study of DNA repair genes, proteins, and processes.

Authors:  J A Eisen; P C Hanawalt
Journal:  Mutat Res       Date:  1999-12-07       Impact factor: 2.433

Review 2.  Avoidance of suicide in antibiotic-producing microbes.

Authors:  Eric Cundliffe; Arnold L Demain
Journal:  J Ind Microbiol Biotechnol       Date:  2010-05-06       Impact factor: 3.346

3.  Isolation, characterization, and heterologous expression of the biosynthesis gene cluster for the antitumor anthracycline steffimycin.

Authors:  Sonia Gullón; Carlos Olano; Mohamed S Abdelfattah; Alfredo F Braña; Jürgen Rohr; Carmen Méndez; José A Salas
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

4.  Doxorubicin overproduction in Streptomyces peucetius: cloning and characterization of the dnrU ketoreductase and dnrV genes and the doxA cytochrome P-450 hydroxylase gene.

Authors:  N Lomovskaya; S L Otten; Y Doi-Katayama; L Fonstein; X C Liu; T Takatsu; A Inventi-Solari; S Filippini; F Torti; A L Colombo; C R Hutchinson
Journal:  J Bacteriol       Date:  1999-01       Impact factor: 3.490

5.  Purification, properties, and characterization of recombinant Streptomyces sp. strain C5 DoxA, a cytochrome P-450 catalyzing multiple steps in doxorubicin biosynthesis.

Authors:  R J Walczak; M L Dickens; N D Priestley; W R Strohl
Journal:  J Bacteriol       Date:  1999-01       Impact factor: 3.490

6.  Development of a Streptomyces venezuelae-based combinatorial biosynthetic system for the production of glycosylated derivatives of doxorubicin and its biosynthetic intermediates.

Authors:  Ah Reum Han; Je Won Park; Mi Kyeong Lee; Yeon Hee Ban; Young Ji Yoo; Eun Ji Kim; Eunji Kim; Byung-Gee Kim; Jae Kyung Sohng; Yeo Joon Yoon
Journal:  Appl Environ Microbiol       Date:  2011-05-20       Impact factor: 4.792

7.  Mutator effects in Escherichia coli caused by the expression of specific foreign genes.

Authors:  Vanessa Gabrovsky; Mitsuko Lynn Yamamoto; Jeffrey H Miller
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

8.  The Streptomyces peucetius dpsY and dnrX genes govern early and late steps of daunorubicin and doxorubicin biosynthesis.

Authors:  N Lomovskaya; Y Doi-Katayama; S Filippini; C Nastro; L Fonstein; M Gallo; A L Colombo; C R Hutchinson
Journal:  J Bacteriol       Date:  1998-05       Impact factor: 3.490

9.  Escherichia coli allows efficient modular incorporation of newly isolated quinomycin biosynthetic enzyme into echinomycin biosynthetic pathway for rational design and synthesis of potent antibiotic unnatural natural product.

Authors:  Kenji Watanabe; Kinya Hotta; Mino Nakaya; Alex P Praseuth; Clay C C Wang; Daiki Inada; Kosaku Takahashi; Eri Fukushi; Hiroki Oguri; Hideaki Oikawa
Journal:  J Am Chem Soc       Date:  2009-07-08       Impact factor: 15.419

10.  Biosynthesis of sibiromycin, a potent antitumor antibiotic.

Authors:  Wei Li; Ankush Khullar; Shenchieh Chou; Ashley Sacramo; Barbara Gerratana
Journal:  Appl Environ Microbiol       Date:  2009-03-06       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.